A health worker holds a syringe and a vial of the Sinovac coronavirus disease (COVID-19) vaccine at a market in Bangkok, Thailand, March 17, 2021. REUTERS FILE PHOTO
BANGKOK — Thailand will stop using the COVID-19 vaccine of China's Sinovac when its current stock finishes, a senior official said on Monday, having used the shot extensively in combination with Western-developed vaccines.
Thailand used over 31.5 million Sinovac doses since February, starting with two doses to frontline workers, high-risk groups and residents of Phuket, a holiday island that reopened to tourists early in a pilot scheme.
In July, Thailand started inoculating people with Sinovac as a first dose followed by the Oxford University-developed AstraZeneca. Thailand was the first country to combine a Chinese and Western shots, a strategy its health officials said has proved effective.
"We expect to have distributed all Sinovac doses this week," said health official Opas Karnkawinpong, adding the program will switch to combining the AstraZeneca vaccine with that made by Pfizer and BioNTech .
Thailand next year plans to buy 120 million COVID-19 vaccine doses in total and has already booked 60 million doses of AstraZeneca, a vaccine it manufactures locally.
Thailand has said it will only procure vaccines effective against new variants.
It has so far vaccinated 36% of the estimated 72 million people who live in Thailand and hopes to reach 70% by year-end.
The country is forging ahead with a quarantine-free reopening plan next month of 17 provinces to vaccinated arrivals from low risk countries. Included will be destinations like Pattaya, Hua Hin, Chiang Mai and Bangkok.
Thailand has recorded nearly 1.8 million cases and 18,336 fatalities overall, more than 98% in the past seven months.
Subscribe to our daily newsletter
- COVID-19 In Pennsylvania: We Could Have A Vaccine Within The Next Month, Dr. Rachel Levine Says
- Clashes between Azerbaijan and Armenia intensify as US steps up efforts to negotiate a ceasefire to bring an end month of bloodshed
- Vaccine trials should NOT be stopped even in the event of death, scientists say as Brazilian doctor, 28, dies from Covid-19 after getting placebo dose in Oxford University's study
- China's state pharmaceutical firm claims it has given experimental coronavirus vaccine to nearly one million people in emergency use
- Here's a look at how the different coronavirus vaccines work
- Where are we in the Covid-19 vaccine race?
- Where are we in the COVID-19 vaccine race?
- Chinese vaccine maker seeks approval for public use of Covid-19 shot
- Chinese experimental Covid-19 vaccine given to 1 million people
- When will we have a COVID-19 vaccine?
- Which Countries Have Already Secured COVID Vaccines by Pfizer and Moderna?
- Chinese Coronavirus Vaccine Taken by Nearly 1 Million People, Company Says
- Vaccine to undergo 3rd phase of trials
- Sounds strange, but there could be too many Covid-19 vaccines
- Coronavirus vaccinations could be under way for ALL adults by the end of January after the most vulnerable get jabs next month, leaked NHS plans show
- Another Covid vaccine breakthrough as Moderna reveals its jab is 94.5% effective - making it BETTER than Pfizer's (but the UK hasn't bought any...)
- Oxford vaccine heroes reveal pride at cracking Covid jab in just nine months
- Pfizer shares hit 52-week high after firm claims its vaccine is over 90% effective
- Matt Hancock says Britain is 'working closely' with Pfizer to roll out the firm's breakthrough Covid-19 vaccine as soon as December 1
- Nasdaq closes at record high as investors bank on vaccine
Thailand to cease Sinovac vaccine use when stocks end this month have 545 words, post on newsinfo.inquirer.net at October 18, 2021. This is cached page on Travel News. If you want remove this page, please contact us.